Xiao Liqing, Caino M Cecilia, von Burstin Vivian A, Oliva Jose L, Kazanietz Marcelo G
Department of Pharmacology and Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
Methods Enzymol. 2008;446:123-39. doi: 10.1016/S0076-6879(08)01607-8.
Protein kinase C (PKC) isozymes catalyze the phosphorylation of substrates that play key roles in the control in proliferation, differentiation, and survival. Treatment of cells with phorbol esters, activators of classical and novel PKC isozymes, leads to a plethora of responses in a strict cell-type-dependent specific manner. Interestingly, a few cell models undergo apoptosis in response to phorbol ester stimulation, including androgen-dependent prostate cancer cells. This effect involves the autocrine secretion of death factors and activation of the extrinsic apoptotic cascade. We have recently found that in other models, such as lung cancer cells, phorbol esters lead to irreversible growth arrest and senescence. This chapter describes the methods we use to assess these phorbol ester responses in cancer cell models, focusing on apoptosis and senescence.
蛋白激酶C(PKC)同工酶催化底物的磷酸化,这些底物在细胞增殖、分化和存活的调控中发挥关键作用。用佛波酯(经典和新型PKC同工酶的激活剂)处理细胞,会以严格的细胞类型依赖性特异性方式引发大量反应。有趣的是,一些细胞模型在佛波酯刺激下会发生凋亡,包括雄激素依赖性前列腺癌细胞。这种效应涉及死亡因子的自分泌分泌和外源性凋亡级联反应的激活。我们最近发现,在其他模型中,如肺癌细胞,佛波酯会导致不可逆的生长停滞和衰老。本章描述了我们用于评估癌细胞模型中这些佛波酯反应的方法,重点是凋亡和衰老。